Xlife Sciences AG / Key word(s): PatentXlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle 20.01.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) announced today that its Swiss portfolio company Axenoll Life Sciences AG has been granted a stra.
Xlife Sciences AG / Key word(s): Half Year Results28-Sep-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Xlife Sciences (SIX: XLS) today published its results for the first half of 2022 ending 30 June 2022. Oliver R. B.
Xlife Sciences AG / Key word: Miscellaneous
Baader Bank initiates research coverage on Xlife Sciences
15.09.2022 / 07:00 CET/CEST
Baader Bank, one of the leading European partners. | September 15, 2022
22.08.2022 - Xlife Sciences AG / Key word(s): Miscellaneous Intron Health initiates research coverage of Xlife Sciences 22.08.2022 / 07:00 CET/CEST Intron Health today published its first independent research report on Xlife Sciences (SIX: XLS). The coverage . Seite 1